It is not generally recommended for exacerbations. Serum concentration monitoring is mandatory. Leukotriene Modifiers . Further clinical experience and research are needed to establish the specific roles of these new medications in asthma therapy. Regularly scheduled daily use is generally not recommended.
Cholinergic innervation is an important factor in the regulation of airway smooth muscle tone.
Ipratropium bromide may provide some additive benefit to inhaled beta 2 agonists in severe exacerbations of asthma. Systemic Corticosteroids . Although the onset of action is slow, they prevent progression of the exacerbation, speed recovery and prevent early relapses. Monitoring Continual monitoring is essential to ensure that asthma control is achieved. In addition, the panel states that any patient who develops severe exacerbations may benefit from peak flow monitoring.